Objective: To revise and expand the 1996 Osteoporosis Society of Canada clinical practice
guidelines for the management of osteoporosis, incorporating recent advances in diagnosis …

Background Osteoporosis is an abnormal reduction in bone mass and bone deterioration
leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of …

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Context.—Alendronate sodium reduces fracture risk in postmenopausal women who have
vertebral fractures, but its effects on fracture risk have not been studied for women without …

Background Treatment intervention thresholds for prevention of osteoporotic fractures can
be derived from reports from the World Health Organization (diagnostic criteria) and National …

Background Bisphosphonate therapy is the current standard of care for the prevention and
treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients …

Handbook of Dairy Foods and Nutrition, Third Edition examines the role of dairy products in
diet and health, covering such areas as cardiovascular health, hypertension, cancer, bone …

The aim of treatment of postmenopausal osteoporosis is to reduce the frequency of vertebral
and non-vertebral fractures (especially at the hip), which are responsible for morbidity …

Perimenopause: The Complex Endocrinology of the Menopausal Transition | Endocrine
Reviews | Oxford Academic Skip to Main Content Advertisement Oxford Academic Journals …

Background Bisphosphonates decrease bone resorption and are commonly used to treat or
prevent osteoporosis. However, the effect of bisphosphonates on their target cells remains …